Skip to main content
. Author manuscript; available in PMC: 2024 Apr 3.
Published in final edited form as: Sci Total Environ. 2022 Jun 27;843:157005. doi: 10.1016/j.scitotenv.2022.157005

Table 1.

Pilot participant characteristics.

Participant 1 Participant 2 Participant 3 Participant 4
Age, yrs 31 33 37 35
BMI, kg/m2 26.6 24.9 22.6 24.3
Race Caucasian Caucasian, Puerto Rican Caucasian
Ethnicity Non-Hispanic Non-Hispanic Hispanic Non-Hispanic
Month collected August August August August
Age at menarche, yrs 12 12 14 13
Typical Cycle Length (time from D1 to D1), days - self report 26–31 26–31 [Getting confirmation] [Getting confirmation]
Typical bleed length, days 7–9 3–5 6 4
Typical menstrual flowa Heavy Moderate Heavy Heavy
Pain at time of collection (Y/N) N Y Y Y
Pain severity at time of collection N/A Severe Mild Moderate
Pain medication used at collection (Y/A) N Y Y Y
Medications/Drugs at time of collection N/A Ibuprofen Naproxen Ibuprofen
Gynecological conditions (Yes/No)
Endometriosis N N Y Y
Adenomysosis N N N N
Pelvic inflammatory disease N N N N
PCOS N N N N
a

Light (using 10 or less pads/tampons per period) Moderate (11–20 pads/tampons per period) Moderately heavy (21–30 pads/tampons per period) Heavy (>30 pads/tampons per period).